Abstract

Supplementary Table 1. The number of individuals with lipid-lowering and diabetes drugs in groups.Supplementary Table 2. Associations between the prevalence of type 2 diabetes and IR-Possible sarcopenia in subjects with IR.Supplementary Table 3. Associations between the prevalence of type 2 diabetes and IR-Sarcopenia.</p

    Similar works

    Full text

    thumbnail-image